Dubai Biotechnology and Research Park (DuBiotech), the major life sciences hub in the Middle East and a member of TECOM Investments' newly created Sciences Cluster, today announced it joined hands with the Ministry of Health to host a workshop, seeking to update its business partners on the regulatory environment in the UAE.
Titled 'The First Regulatory Gathering', the workshop held at the DuBiotech Laboratory buildings was led by His Excellency Dr. Amin Al Amiri, CEO, Medical Practice and Licences, UAE Ministry of Health, who briefed DuBiotech business partners on the regulatory framework in the UAE as well as the challenges to the industry's growth.
His Excellency Dr. Al Amiri said: "The workshop served as a crucial platform to critically examine the medical sector in the UAE. The Ministry of Health is committed to supporting government and private sector organizations in developing the region's industry. DuBiotech's initiative with the ministry has been significant as it helped bring better synergy in teamwork and alliance, paving the way for future collaborations."
Dr Marco Baccanti, Executive Director, DuBiotech, said: "DuBiotech is always keen to collaborate with ministries and government bodies to ensure that companies operating within the life sciences park comply with legislations and regulations. The joint workshop was part of our initiative to help our business partners clear regulatory-related issues with the ministry officials."
Launched in 2005, the Dubai Biotechnology and Research Park has the mission to create the biggest life sciences cluster in the Middle East. Its business model is based on providing the best environment for major players in the life sciences industry and research through adopting a sustainable strategy and leveraging the benefits of its location in Dubai, while offering free zone benefits and creating world class infrastructure.
